Searched for
PATENT INFRINGEMENT INDIA
Former Tips Music CEO Hari Nair joins AI content protection startup ContentLens as strategic advisorContentLens has appointed Hari Nair as a pro bono strategic advisor. Nair previously led Tips Music and held roles at Sony Music India and ...- IT’s Rs 18 lakh crore m-cap rout; Info Edge, Ixigo post Q4 profitsA multi-month bear market has hit the valuations of India’s top 10 digital and technology services exporters. This and more in today’s ETte...
- India won't have to rely on foreign suppliers for new-gen refrigerant gases, says SRF's Ashish Bharat RamThe new refrigerants called hydrofluoroolefins, or HFOs, are quickly replacing older hydrofluorocarbons, or HFCs, in the USA and Europe as ...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Delhi HC allows Dr. Reddy’s to export weight-loss drug semaglutide, calls Novo Nordisk’s case ‘weak’The Delhi High Court declined to stay a single-judge order allowing Dr. Reddy's to export its semaglutide, observing Novo Nordisk's appeal ...
- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Natco Pharma sues Novo Nordisk in generic drug pushThe lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its...
- GSK files patent suit against GlenmarkGSK was granted a patent for vilanterol in India in 2007. The patent expires in September 2022.
- InterDigital files two patent infringement complaint against Xiaomi in IndiaThe US-based R&D firm is seeking compensatory and punitive damages for alleged infringement of its Indian patents by the largest handset ma...
- Delhi High Court restrains Cipla from selling drug containing IndacaterolHC temporarily restrained Cipla from manufacturing, importing or selling any drug containing the chemical Indacaterol.
- Sun Pharma takes Novartis to US Court, seeks permission to market Glivec in USUntil and unless Sun obtains a court decision of non-infringement and/or invalidity on the ’051 patent, it faces the risk of patent infring...
- Merck unit sues Glenmark Pharmaceuticals for infringing patent on diabetes drugsA unit of US drugmaker Merck & Co sued India's Glenmark Pharmaceuticals on Tuesday for infringing its patent on two diabetes drugs.
- Indian pharma sector fears India-European Union FTA could imperil local industryDrugmakers are worried that the India-EU FTA, which is in the works, may contain a provision that could imperil local industry.
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Delhi High Court dismisses Roche's patent suit against CiplaThe Delhi HC dismissed Hoffmann-La Roche's suit accusing Cipla of infringing the Swiss company's patent for its lung cancer medicine Tarcev...
- SC quashes Bayer petition to block Cipla generic drugThe country’s top judicial authority has dismissed German pharmaceutical firm Bayer AG’s attempt to block Indian drug regulator from allowi...
- Bayer drags Cipla to court over patentGerman drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drug seller, to stop the Mumbai-based compa...
- Dr Reddy’s Lab embroiled in patent infringement row with AMRINYSE listed Dr Reddy’s Laboratories (DRL), India’s second largest company by revenue, is embroiled in a fresh patent infringement row with ...
- Why should DCGI play custodian to private rights?India should adopt US-Canadian model of linking marketing authorisation by the regulatory authority (Drugs Controller General of India) to ...
- Ranbaxy wins on two additional patents in NorwayIn yet another boost to India's biggest drug maker Ranbaxy Laboratories, a Norwegian court has ruled in its favour in the patent litigation...
Load More
